S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
NASDAQ:OFIX

Orthofix Medical (OFIX) Stock Price, News & Analysis

$14.52
+0.23 (+1.61%)
(As of 03/28/2024 ET)
Today's Range
$14.22
$14.76
50-Day Range
$13.00
$14.62
52-Week Range
$9.57
$21.60
Volume
248,060 shs
Average Volume
397,670 shs
Market Capitalization
$543.19 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.50

Orthofix Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
6.7% Upside
$15.50 Price Target
Short Interest
Bearish
9.92% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.45mentions of Orthofix Medical in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.51) to ($0.69) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.38 out of 5 stars

Medical Sector

907th out of 939 stocks

Surgical & Medical Instruments Industry

95th out of 97 stocks

OFIX stock logo

About Orthofix Medical Stock (NASDAQ:OFIX)

Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

OFIX Stock Price History

OFIX Stock News Headlines

Trump’s “Tax Free” Retirement Strategy
Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.
Orthofix Medical Inc. (OM2.F)
Q4 2023 Orthofix Medical Inc Earnings Call
Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Orthofix Medical Preliminary Q4 Net Sales Up 63.8% - Quick Facts
Orthofix Medical appoints CEO, CFO
Orthofix Medical: Under New Management
See More Headlines
Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/05/2024
Today
3/29/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,634
Year Founded
1980

Price Target and Rating

Average Stock Price Target
$15.50
High Stock Price Target
$16.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+6.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$-151,400,000.00
Pretax Margin
-19.91%

Debt

Sales & Book Value

Annual Sales
$746.64 million
Book Value
$16.11 per share

Miscellaneous

Free Float
35,649,000
Market Cap
$543.19 million
Optionable
Optionable
Beta
1.03

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Ms. Kimberley A. EltingMs. Kimberley A. Elting (Age 59)
    President of Global Orthopedics
    Comp: $766.67k
  • Mr. Kevin J. Kenny (Age 59)
    President of Global Spine Business
    Comp: $607.64k
  • Mr. Massimo Calafiore
    President, CEO & Director
  • Ms. Julie B. Andrews (Age 53)
    Chief Financial Officer
  • Mr. Roberto Donadello
    Senior Vice President of Global Operations
  • Dr. Frank Vizesi Ph.D.
    Chief Scientific Officer
  • Mr. Dan E. Yarbrough
    Vice President of Investor Relations
  • Ms. Jill Mason
    Interim Chief Ethics & Compliance Officer and VP of Corporate Counsel
  • Ms. Suzanne Armstrong
    Chief Human Resources Officer
  • Mr. Ehab M. Esmail (Age 52)
    Senior Vice President of Global Quality, Regulatory & Clinical Affairs

OFIX Stock Analysis - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OFIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OFIX, but not buy additional shares or sell existing shares.
View OFIX analyst ratings
or view top-rated stocks.

What is Orthofix Medical's stock price target for 2024?

3 Wall Street research analysts have issued 1 year target prices for Orthofix Medical's stock. Their OFIX share price targets range from $15.00 to $16.00. On average, they anticipate the company's share price to reach $15.50 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price.
View analysts price targets for OFIX
or view top-rated stocks among Wall Street analysts.

How have OFIX shares performed in 2024?

Orthofix Medical's stock was trading at $13.48 at the beginning of the year. Since then, OFIX shares have increased by 7.7% and is now trading at $14.52.
View the best growth stocks for 2024 here
.

When is Orthofix Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our OFIX earnings forecast
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) released its quarterly earnings results on Tuesday, March, 5th. The medical device company reported ($0.59) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.60) by $0.01. The medical device company had revenue of $200.42 million for the quarter. Orthofix Medical had a negative net margin of 20.28% and a negative trailing twelve-month return on equity of 10.63%.

What ETF holds Orthofix Medical's stock?

Syntax Stratified SmallCap ETF holds 3,764 shares of OFIX stock, representing 0.39% of its portfolio.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $785.0 million-$795.0 million, compared to the consensus revenue estimate of $798.6 million.

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Rubric Capital Management LP (9.97%), Armistice Capital LLC (9.79%), Engine Capital Management LP (8.26%), Vanguard Group Inc. (5.44%), Vanguard Group Inc. (5.44%) and Newtyn Management LLC (2.87%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kevin J Kenny, Kimberley A Elting, Michael E Paolucci, Rice Doug and Shweta Maniar.
View institutional ownership trends
.

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OFIX) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners